+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Asthma Spacers Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797879
The global asthma spacers market size attained a value of USD 1.72 billion in 2022. The market is anticipated to grow at a CAGR of 5.1% during the forecast period of 2023-2031 to attain a value of USD 2.69 billion by 2031.

Asthma Spacers Market: Introduction

Asthma spacers, also known as aerosol-holding chambers or valved holding chambers, are medical devices used in combination with metered-dose inhalers (MDIs) to improve the delivery of inhaled medications for asthma and other respiratory conditions. Spacers are typically made of plastic and consist of a tube or chamber with a mouthpiece or mask on one end and an opening to attach the MDI on the other end.

Uses and benefits of asthma spacers:
1. Improved medication delivery: When using an MDI alone, a significant portion of the medication can end up in the mouth, throat, or stomach, rather than the lungs where it is needed. Spacers help ensure that more medication reaches the lungs by creating a temporary space for the aerosolized drug to slow down and mix with the air, making it easier to inhale the medication effectively.
2. Better coordination: Some people, especially children and the elderly, may have difficulty coordinating their breath with the actuation of the MDI. Spacers provide a buffer, allowing the user to inhale the medication at their own pace, reducing the risk of poor inhaler technique and ensuring optimal medication delivery.
3. Reduced side effects: By ensuring that more medication reaches the lungs and less remains in the mouth and throat, spacers can help reduce the risk of side effects associated with inhaled corticosteroids, such as oral thrush or hoarseness.
4. Enhanced treatment efficacy: As spacers improve the delivery of inhaled medications, they can enhance the efficacy of asthma treatment, leading to better symptom control, reduced risk of asthma exacerbations, and improved quality of life for patients.

In summary, asthma spacers are valuable tools that can improve the delivery of inhaled medications, enhance treatment efficacy, and reduce side effects. They are particularly useful for children, the elderly, and individuals who have difficulty coordinating their breath with the use of an MDI alone. Healthcare providers often recommend the use of spacers for patients with asthma and other respiratory conditions to ensure optimal treatment outcomes.

Asthma Spacers Market Segmentations

The market can be categorised into type, distribution channel, and region.

Market Breakup by Type

  • Volumatic
  • Aerochamber
  • InspirEase
  • Optichamber
  • Others

Market Breakup by Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Asthma Spacers Market Scenario

The global asthma spacers market is driven by the increasing prevalence of asthma and other respiratory conditions that require the use of inhaled medications. Asthma spacers, also known as aerosol-holding chambers or valved holding chambers, are essential devices that improve medication delivery, coordination, and reduce side effects for patients using metered-dose inhalers (MDIs). The market encompasses various aspects, including the production and distribution of asthma spacers, as well as research and development of new and improved spacer designs.

Market Drivers

Key factors propelling the asthma spacers market include the growing global prevalence of asthma, which affects approximately 339 million people worldwide according to the World Health Organization (WHO), and the increasing awareness of the benefits of using spacers with MDIs. Additionally, the market is driven by the aging population, which may face challenges in coordinating their breath with MDIs, and the focus on improving asthma management and treatment outcomes. Furthermore, advancements in technology and materials used for spacer production contribute to the market's growth.

Market Challenges

Despite the growing demand for asthma spacers, the market faces some challenges. Affordability and accessibility of spacers may be limited, particularly in low- and middle-income countries where healthcare resources are constrained. Furthermore, a lack of awareness about the benefits of using spacers with MDIs may result in underutilization and suboptimal treatment outcomes for patients with asthma and other respiratory conditions.

Regional Analysis

Geographically, the global asthma spacers market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates the market due to its advanced healthcare infrastructure, increased awareness about asthma management, and the presence of key market players. Europe follows closely, while Asia Pacific is anticipated to be the fastest-growing region due to the increasing prevalence of asthma, improving healthcare infrastructure, and rising healthcare expenditures in the region.

Future Outlook

The asthma spacers market is expected to continue growing in the coming years, primarily driven by the increasing prevalence of asthma and other respiratory conditions, advancements in spacer technology, and improved access to healthcare services. As new technologies emerge and healthcare systems continue to evolve, the market may experience increased access to asthma spacers, resulting in better asthma management and improved patient outcomes worldwide.

Key Players in the Global Asthma Spacers Market

The report gives an in-depth analysis of the key players involved in the asthma spacers market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Trudell Medical International
  • PARI Respiratory Equipment, Inc
  • Koninklijke Philips N.V
  • GlaxoSmithKline plc
  • Intervet Inc
  • Lupin
  • Cipla Inc
  • Medical Developments International
  • Visiomed Group Ltd.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asthma Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Asthma Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Asthma Epidemiology (2016-2031)
5.3 Europe Asthma Epidemiology (2016-2031)
5.4 Asia-Pacific Asthma Epidemiology (2016-2031)
5.5 Latin America Asthma Epidemiology (2016-2031)
5.6 Middle East & Africa Asthma Epidemiology (2016-2031)
6 Global Asthma Spacers Market Overview
6.1 Global Asthma Spacers Market Historical Value (2016-2022)
6.2 Global Asthma Spacers Market Forecast Value (2023-2031)
7 Global Asthma Spacers Market Landscape
7.1 Asthma Spacers: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Asthma Spacers: Product Landscape
7.2.1 Analysis by Type
7.2.2 Analysis by Distribution Channel
8 Asthma Spacers Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Asthma Spacers Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Asthma Spacers Market Segmentation
11.1 Global Asthma Spacers Market by Type
11.1.1 Market Overview
11.1.2 Volumatic
11.1.3 Aerochamber
11.1.4 InspirEase
11.1.5 Optichamber
11.1.6 Others
11.2 Global Asthma Spacers Market by Distribution Channel
11.2.1 Market Overview
11.2.2 Hospitals Pharmacy
11.2.3 Retail Pharmacy
11.2.4 Online Pharmacy
11.2.5 Others
11.3 Global Asthma Spacers Market by Region
11.3.1 Market Overview
11.3.2 North America
11.3.3 Europe
11.3.4 Asia Pacific
11.3.5 Latin America
11.3.6 Middle East and Africa
12 North America Asthma Spacers Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Asthma Spacers Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Asthma Spacers Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Asthma Spacers Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Asthma Spacers Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Funding and Investment Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Supplier Landscape
22.1 Trudell Medical International
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 PARI Respiratory Equipment, Inc.
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Koninklijke Philips N.V
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 GlaxoSmithKline plc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 Intervet Inc.
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Lupin
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 Cipla Inc.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 Medical Developments International
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 HAAG-STREIT Group
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Visiomed Group Ltd.
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
23 Asthma Spacers - Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket

Companies Mentioned

  • Trudell Medical International
  • Pari Respiratory Equipment, Inc.
  • Koninklijke Philips N.V
  • GlaxoSmithKline plc.
  • Intervet Inc.
  • Lupin
  • Cipla Inc.
  • Medical Developments International
  • Haag-Streit Group
  • Visiomed Group Ltd.



Table Information